nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—ABCB1—Mitomycin—stomach cancer	0.104	0.212	CbGbCtD
Temsirolimus—CYP3A7—Irinotecan—stomach cancer	0.0546	0.112	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.0546	0.112	CbGbCtD
Temsirolimus—CYP3A5—Irinotecan—stomach cancer	0.0409	0.0837	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.04	0.0818	CbGbCtD
Temsirolimus—CYP3A7—Docetaxel—stomach cancer	0.04	0.0818	CbGbCtD
Temsirolimus—CYP3A5—Docetaxel—stomach cancer	0.03	0.0614	CbGbCtD
Temsirolimus—ABCB1—Irinotecan—stomach cancer	0.0266	0.0545	CbGbCtD
Temsirolimus—ABCB1—Docetaxel—stomach cancer	0.0195	0.0399	CbGbCtD
Temsirolimus—CYP3A4—Irinotecan—stomach cancer	0.016	0.0327	CbGbCtD
Temsirolimus—ABCB1—Doxorubicin—stomach cancer	0.0146	0.0298	CbGbCtD
Temsirolimus—ABCB1—Methotrexate—stomach cancer	0.0141	0.0288	CbGbCtD
Temsirolimus—CYP2D6—Doxorubicin—stomach cancer	0.0137	0.0281	CbGbCtD
Temsirolimus—CYP3A4—Docetaxel—stomach cancer	0.0117	0.0239	CbGbCtD
Temsirolimus—CYP3A4—Doxorubicin—stomach cancer	0.00872	0.0178	CbGbCtD
Temsirolimus—MTOR—blood vessel—stomach cancer	0.00521	0.0858	CbGeAlD
Temsirolimus—MTOR—hematopoietic system—stomach cancer	0.00277	0.0457	CbGeAlD
Temsirolimus—MTOR—epithelium—stomach cancer	0.00254	0.0418	CbGeAlD
Temsirolimus—FKBP1A—hematopoietic system—stomach cancer	0.00249	0.0411	CbGeAlD
Temsirolimus—MTOR—smooth muscle tissue—stomach cancer	0.00244	0.0403	CbGeAlD
Temsirolimus—FKBP1A—epithelium—stomach cancer	0.00228	0.0376	CbGeAlD
Temsirolimus—MTOR—pancreas—stomach cancer	0.00226	0.0372	CbGeAlD
Temsirolimus—FKBP1A—smooth muscle tissue—stomach cancer	0.0022	0.0362	CbGeAlD
Temsirolimus—FKBP1A—pancreas—stomach cancer	0.00203	0.0335	CbGeAlD
Temsirolimus—MTOR—lymphoid tissue—stomach cancer	0.00195	0.0322	CbGeAlD
Temsirolimus—MTOR—digestive system—stomach cancer	0.00193	0.0318	CbGeAlD
Temsirolimus—MTOR—bone marrow—stomach cancer	0.00178	0.0293	CbGeAlD
Temsirolimus—CYP3A7—endocrine gland—stomach cancer	0.00177	0.0292	CbGeAlD
Temsirolimus—FKBP1A—lymphoid tissue—stomach cancer	0.00176	0.0289	CbGeAlD
Temsirolimus—FKBP1A—digestive system—stomach cancer	0.00173	0.0286	CbGeAlD
Temsirolimus—FKBP1A—bone marrow—stomach cancer	0.0016	0.0264	CbGeAlD
Temsirolimus—CYP3A7—liver—stomach cancer	0.0016	0.0264	CbGeAlD
Temsirolimus—MTOR—endocrine gland—stomach cancer	0.00159	0.0263	CbGeAlD
Temsirolimus—MTOR—liver—stomach cancer	0.00144	0.0237	CbGeAlD
Temsirolimus—FKBP1A—endocrine gland—stomach cancer	0.00143	0.0236	CbGeAlD
Temsirolimus—CYP3A7-CYP3A51P—liver—stomach cancer	0.00136	0.0224	CbGeAlD
Temsirolimus—FKBP1A—liver—stomach cancer	0.00129	0.0213	CbGeAlD
Temsirolimus—MTOR—lymph node—stomach cancer	0.0011	0.0182	CbGeAlD
Temsirolimus—CYP3A5—hematopoietic system—stomach cancer	0.00109	0.0179	CbGeAlD
Temsirolimus—ABCB1—blood vessel—stomach cancer	0.00108	0.0179	CbGeAlD
Temsirolimus—FKBP1A—lymph node—stomach cancer	0.000991	0.0163	CbGeAlD
Temsirolimus—CYP3A5—pancreas—stomach cancer	0.000884	0.0146	CbGeAlD
Temsirolimus—CYP3A4—hematopoietic system—stomach cancer	0.000815	0.0134	CbGeAlD
Temsirolimus—CYP2D6—hematopoietic system—stomach cancer	0.000802	0.0132	CbGeAlD
Temsirolimus—CYP3A5—digestive system—stomach cancer	0.000755	0.0125	CbGeAlD
Temsirolimus—CYP3A5—endocrine gland—stomach cancer	0.000624	0.0103	CbGeAlD
Temsirolimus—ABCB1—hematopoietic system—stomach cancer	0.000577	0.00951	CbGeAlD
Temsirolimus—CYP3A4—digestive system—stomach cancer	0.000567	0.00934	CbGeAlD
Temsirolimus—CYP3A5—liver—stomach cancer	0.000563	0.00928	CbGeAlD
Temsirolimus—CYP2D6—digestive system—stomach cancer	0.000558	0.0092	CbGeAlD
Temsirolimus—ABCB1—epithelium—stomach cancer	0.000527	0.00869	CbGeAlD
Temsirolimus—ABCB1—pancreas—stomach cancer	0.00047	0.00774	CbGeAlD
Temsirolimus—CYP3A4—endocrine gland—stomach cancer	0.000468	0.00772	CbGeAlD
Temsirolimus—CYP2D6—endocrine gland—stomach cancer	0.000461	0.0076	CbGeAlD
Temsirolimus—CYP3A4—liver—stomach cancer	0.000422	0.00696	CbGeAlD
Temsirolimus—CYP2D6—liver—stomach cancer	0.000416	0.00685	CbGeAlD
Temsirolimus—ABCB1—lymphoid tissue—stomach cancer	0.000406	0.0067	CbGeAlD
Temsirolimus—ABCB1—digestive system—stomach cancer	0.000401	0.00661	CbGeAlD
Temsirolimus—ABCB1—bone marrow—stomach cancer	0.00037	0.0061	CbGeAlD
Temsirolimus—ABCB1—endocrine gland—stomach cancer	0.000332	0.00547	CbGeAlD
Temsirolimus—ABCB1—liver—stomach cancer	0.000299	0.00493	CbGeAlD
Temsirolimus—ABCB1—lymph node—stomach cancer	0.000229	0.00378	CbGeAlD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000157	0.000575	CcSEcCtD
Temsirolimus—Urinary tract disorder—Methotrexate—stomach cancer	0.000156	0.000575	CcSEcCtD
Temsirolimus—Anaphylactic shock—Docetaxel—stomach cancer	0.000156	0.000573	CcSEcCtD
Temsirolimus—Oedema—Docetaxel—stomach cancer	0.000156	0.000573	CcSEcCtD
Temsirolimus—Epistaxis—Epirubicin—stomach cancer	0.000156	0.000572	CcSEcCtD
Temsirolimus—Urethral disorder—Methotrexate—stomach cancer	0.000155	0.00057	CcSEcCtD
Temsirolimus—Infection—Docetaxel—stomach cancer	0.000155	0.00057	CcSEcCtD
Temsirolimus—Weight decreased—Doxorubicin—stomach cancer	0.000155	0.000569	CcSEcCtD
Temsirolimus—Sinusitis—Epirubicin—stomach cancer	0.000155	0.000569	CcSEcCtD
Temsirolimus—Hyperglycaemia—Doxorubicin—stomach cancer	0.000155	0.000568	CcSEcCtD
Temsirolimus—Diarrhoea—Irinotecan—stomach cancer	0.000154	0.000568	CcSEcCtD
Temsirolimus—Pneumonia—Doxorubicin—stomach cancer	0.000154	0.000564	CcSEcCtD
Temsirolimus—Nervous system disorder—Docetaxel—stomach cancer	0.000153	0.000562	CcSEcCtD
Temsirolimus—Pruritus—Fluorouracil—stomach cancer	0.000153	0.000562	CcSEcCtD
Temsirolimus—Thrombocytopenia—Docetaxel—stomach cancer	0.000153	0.000562	CcSEcCtD
Temsirolimus—Infestation NOS—Doxorubicin—stomach cancer	0.000153	0.000561	CcSEcCtD
Temsirolimus—Infestation—Doxorubicin—stomach cancer	0.000153	0.000561	CcSEcCtD
Temsirolimus—Skin disorder—Docetaxel—stomach cancer	0.000152	0.000557	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000151	0.000556	CcSEcCtD
Temsirolimus—Oedema—Capecitabine—stomach cancer	0.000151	0.000555	CcSEcCtD
Temsirolimus—Renal failure—Doxorubicin—stomach cancer	0.00015	0.000552	CcSEcCtD
Temsirolimus—Infection—Capecitabine—stomach cancer	0.00015	0.000552	CcSEcCtD
Temsirolimus—Erythema multiforme—Methotrexate—stomach cancer	0.00015	0.00055	CcSEcCtD
Temsirolimus—Dizziness—Irinotecan—stomach cancer	0.000149	0.000549	CcSEcCtD
Temsirolimus—Stomatitis—Doxorubicin—stomach cancer	0.000149	0.000547	CcSEcCtD
Temsirolimus—Anorexia—Docetaxel—stomach cancer	0.000149	0.000547	CcSEcCtD
Temsirolimus—Rhinitis—Epirubicin—stomach cancer	0.000149	0.000546	CcSEcCtD
Temsirolimus—Urinary tract infection—Doxorubicin—stomach cancer	0.000148	0.000545	CcSEcCtD
Temsirolimus—Conjunctivitis—Doxorubicin—stomach cancer	0.000148	0.000545	CcSEcCtD
Temsirolimus—Nervous system disorder—Capecitabine—stomach cancer	0.000148	0.000545	CcSEcCtD
Temsirolimus—Eye disorder—Methotrexate—stomach cancer	0.000148	0.000544	CcSEcCtD
Temsirolimus—Diarrhoea—Fluorouracil—stomach cancer	0.000148	0.000544	CcSEcCtD
Temsirolimus—Thrombocytopenia—Capecitabine—stomach cancer	0.000148	0.000544	CcSEcCtD
Temsirolimus—Pharyngitis—Epirubicin—stomach cancer	0.000147	0.00054	CcSEcCtD
Temsirolimus—Cardiac disorder—Methotrexate—stomach cancer	0.000147	0.00054	CcSEcCtD
Temsirolimus—Skin disorder—Capecitabine—stomach cancer	0.000147	0.000539	CcSEcCtD
Temsirolimus—Urinary tract disorder—Epirubicin—stomach cancer	0.000146	0.000538	CcSEcCtD
Temsirolimus—Oedema peripheral—Epirubicin—stomach cancer	0.000146	0.000536	CcSEcCtD
Temsirolimus—Haematuria—Doxorubicin—stomach cancer	0.000146	0.000535	CcSEcCtD
Temsirolimus—Connective tissue disorder—Epirubicin—stomach cancer	0.000146	0.000535	CcSEcCtD
Temsirolimus—Urethral disorder—Epirubicin—stomach cancer	0.000145	0.000534	CcSEcCtD
Temsirolimus—Epistaxis—Doxorubicin—stomach cancer	0.000144	0.000529	CcSEcCtD
Temsirolimus—Anorexia—Capecitabine—stomach cancer	0.000144	0.000529	CcSEcCtD
Temsirolimus—Angiopathy—Methotrexate—stomach cancer	0.000144	0.000528	CcSEcCtD
Temsirolimus—Vomiting—Irinotecan—stomach cancer	0.000144	0.000527	CcSEcCtD
Temsirolimus—Sinusitis—Doxorubicin—stomach cancer	0.000143	0.000526	CcSEcCtD
Temsirolimus—Immune system disorder—Methotrexate—stomach cancer	0.000143	0.000526	CcSEcCtD
Temsirolimus—Dizziness—Fluorouracil—stomach cancer	0.000143	0.000525	CcSEcCtD
Temsirolimus—Mediastinal disorder—Methotrexate—stomach cancer	0.000143	0.000524	CcSEcCtD
Temsirolimus—Rash—Irinotecan—stomach cancer	0.000142	0.000523	CcSEcCtD
Temsirolimus—Dermatitis—Irinotecan—stomach cancer	0.000142	0.000523	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000142	0.000523	CcSEcCtD
Temsirolimus—Chills—Methotrexate—stomach cancer	0.000142	0.000522	CcSEcCtD
Temsirolimus—Headache—Irinotecan—stomach cancer	0.000141	0.00052	CcSEcCtD
Temsirolimus—Insomnia—Docetaxel—stomach cancer	0.000141	0.000519	CcSEcCtD
Temsirolimus—Erythema multiforme—Epirubicin—stomach cancer	0.00014	0.000515	CcSEcCtD
Temsirolimus—Dyspnoea—Docetaxel—stomach cancer	0.000139	0.000511	CcSEcCtD
Temsirolimus—Somnolence—Docetaxel—stomach cancer	0.000139	0.00051	CcSEcCtD
Temsirolimus—Mental disorder—Methotrexate—stomach cancer	0.000139	0.00051	CcSEcCtD
Temsirolimus—Eye disorder—Epirubicin—stomach cancer	0.000138	0.000509	CcSEcCtD
Temsirolimus—Malnutrition—Methotrexate—stomach cancer	0.000138	0.000506	CcSEcCtD
Temsirolimus—Erythema—Methotrexate—stomach cancer	0.000138	0.000506	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000138	0.000506	CcSEcCtD
Temsirolimus—Cardiac disorder—Epirubicin—stomach cancer	0.000138	0.000505	CcSEcCtD
Temsirolimus—Vomiting—Fluorouracil—stomach cancer	0.000138	0.000505	CcSEcCtD
Temsirolimus—Rhinitis—Doxorubicin—stomach cancer	0.000137	0.000505	CcSEcCtD
Temsirolimus—Insomnia—Capecitabine—stomach cancer	0.000137	0.000502	CcSEcCtD
Temsirolimus—Rash—Fluorouracil—stomach cancer	0.000136	0.000501	CcSEcCtD
Temsirolimus—Dermatitis—Fluorouracil—stomach cancer	0.000136	0.000501	CcSEcCtD
Temsirolimus—Pharyngitis—Doxorubicin—stomach cancer	0.000136	0.0005	CcSEcCtD
Temsirolimus—Decreased appetite—Docetaxel—stomach cancer	0.000136	0.000499	CcSEcCtD
Temsirolimus—Headache—Fluorouracil—stomach cancer	0.000135	0.000498	CcSEcCtD
Temsirolimus—Urinary tract disorder—Doxorubicin—stomach cancer	0.000135	0.000498	CcSEcCtD
Temsirolimus—Oedema peripheral—Doxorubicin—stomach cancer	0.000135	0.000496	CcSEcCtD
Temsirolimus—Dysgeusia—Methotrexate—stomach cancer	0.000135	0.000496	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000135	0.000495	CcSEcCtD
Temsirolimus—Connective tissue disorder—Doxorubicin—stomach cancer	0.000135	0.000495	CcSEcCtD
Temsirolimus—Dyspnoea—Capecitabine—stomach cancer	0.000135	0.000495	CcSEcCtD
Temsirolimus—Fatigue—Docetaxel—stomach cancer	0.000135	0.000494	CcSEcCtD
Temsirolimus—Angiopathy—Epirubicin—stomach cancer	0.000134	0.000494	CcSEcCtD
Temsirolimus—Urethral disorder—Doxorubicin—stomach cancer	0.000134	0.000494	CcSEcCtD
Temsirolimus—Nausea—Irinotecan—stomach cancer	0.000134	0.000493	CcSEcCtD
Temsirolimus—Immune system disorder—Epirubicin—stomach cancer	0.000134	0.000492	CcSEcCtD
Temsirolimus—Mediastinal disorder—Epirubicin—stomach cancer	0.000134	0.000491	CcSEcCtD
Temsirolimus—Constipation—Docetaxel—stomach cancer	0.000133	0.00049	CcSEcCtD
Temsirolimus—Pain—Docetaxel—stomach cancer	0.000133	0.00049	CcSEcCtD
Temsirolimus—Back pain—Methotrexate—stomach cancer	0.000133	0.00049	CcSEcCtD
Temsirolimus—Chills—Epirubicin—stomach cancer	0.000133	0.000489	CcSEcCtD
Temsirolimus—Decreased appetite—Capecitabine—stomach cancer	0.000131	0.000483	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00013	0.000479	CcSEcCtD
Temsirolimus—Fatigue—Capecitabine—stomach cancer	0.00013	0.000479	CcSEcCtD
Temsirolimus—Mental disorder—Epirubicin—stomach cancer	0.00013	0.000477	CcSEcCtD
Temsirolimus—Erythema multiforme—Doxorubicin—stomach cancer	0.00013	0.000476	CcSEcCtD
Temsirolimus—Pain—Capecitabine—stomach cancer	0.000129	0.000475	CcSEcCtD
Temsirolimus—Constipation—Capecitabine—stomach cancer	0.000129	0.000475	CcSEcCtD
Temsirolimus—Malnutrition—Epirubicin—stomach cancer	0.000129	0.000474	CcSEcCtD
Temsirolimus—Erythema—Epirubicin—stomach cancer	0.000129	0.000474	CcSEcCtD
Temsirolimus—Nausea—Fluorouracil—stomach cancer	0.000128	0.000472	CcSEcCtD
Temsirolimus—Eye disorder—Doxorubicin—stomach cancer	0.000128	0.000471	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Docetaxel—stomach cancer	0.000128	0.000469	CcSEcCtD
Temsirolimus—Anaemia—Methotrexate—stomach cancer	0.000127	0.000468	CcSEcCtD
Temsirolimus—Cardiac disorder—Doxorubicin—stomach cancer	0.000127	0.000468	CcSEcCtD
Temsirolimus—Dysgeusia—Epirubicin—stomach cancer	0.000126	0.000464	CcSEcCtD
Temsirolimus—Back pain—Epirubicin—stomach cancer	0.000125	0.000458	CcSEcCtD
Temsirolimus—Angiopathy—Doxorubicin—stomach cancer	0.000124	0.000457	CcSEcCtD
Temsirolimus—Immune system disorder—Doxorubicin—stomach cancer	0.000124	0.000455	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Capecitabine—stomach cancer	0.000124	0.000454	CcSEcCtD
Temsirolimus—Mediastinal disorder—Doxorubicin—stomach cancer	0.000124	0.000454	CcSEcCtD
Temsirolimus—Body temperature increased—Docetaxel—stomach cancer	0.000123	0.000453	CcSEcCtD
Temsirolimus—Abdominal pain—Docetaxel—stomach cancer	0.000123	0.000453	CcSEcCtD
Temsirolimus—Leukopenia—Methotrexate—stomach cancer	0.000123	0.000453	CcSEcCtD
Temsirolimus—Chills—Doxorubicin—stomach cancer	0.000123	0.000452	CcSEcCtD
Temsirolimus—Cough—Methotrexate—stomach cancer	0.00012	0.000442	CcSEcCtD
Temsirolimus—Mental disorder—Doxorubicin—stomach cancer	0.00012	0.000441	CcSEcCtD
Temsirolimus—Abdominal pain—Capecitabine—stomach cancer	0.000119	0.000439	CcSEcCtD
Temsirolimus—Body temperature increased—Capecitabine—stomach cancer	0.000119	0.000439	CcSEcCtD
Temsirolimus—Convulsion—Methotrexate—stomach cancer	0.000119	0.000439	CcSEcCtD
Temsirolimus—Malnutrition—Doxorubicin—stomach cancer	0.000119	0.000439	CcSEcCtD
Temsirolimus—Erythema—Doxorubicin—stomach cancer	0.000119	0.000439	CcSEcCtD
Temsirolimus—Anaemia—Epirubicin—stomach cancer	0.000119	0.000438	CcSEcCtD
Temsirolimus—Arthralgia—Methotrexate—stomach cancer	0.000117	0.000431	CcSEcCtD
Temsirolimus—Chest pain—Methotrexate—stomach cancer	0.000117	0.000431	CcSEcCtD
Temsirolimus—Myalgia—Methotrexate—stomach cancer	0.000117	0.000431	CcSEcCtD
Temsirolimus—Dysgeusia—Doxorubicin—stomach cancer	0.000117	0.000429	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000117	0.000428	CcSEcCtD
Temsirolimus—Leukopenia—Epirubicin—stomach cancer	0.000115	0.000424	CcSEcCtD
Temsirolimus—Back pain—Doxorubicin—stomach cancer	0.000115	0.000424	CcSEcCtD
Temsirolimus—Hypersensitivity—Docetaxel—stomach cancer	0.000115	0.000423	CcSEcCtD
Temsirolimus—Cough—Epirubicin—stomach cancer	0.000113	0.000414	CcSEcCtD
Temsirolimus—Anaphylactic shock—Methotrexate—stomach cancer	0.000113	0.000413	CcSEcCtD
Temsirolimus—Asthenia—Docetaxel—stomach cancer	0.000112	0.000411	CcSEcCtD
Temsirolimus—Convulsion—Epirubicin—stomach cancer	0.000112	0.000411	CcSEcCtD
Temsirolimus—Infection—Methotrexate—stomach cancer	0.000112	0.000411	CcSEcCtD
Temsirolimus—Hypertension—Epirubicin—stomach cancer	0.000111	0.000409	CcSEcCtD
Temsirolimus—Hypersensitivity—Capecitabine—stomach cancer	0.000111	0.000409	CcSEcCtD
Temsirolimus—Pruritus—Docetaxel—stomach cancer	0.00011	0.000406	CcSEcCtD
Temsirolimus—Nervous system disorder—Methotrexate—stomach cancer	0.00011	0.000405	CcSEcCtD
Temsirolimus—Anaemia—Doxorubicin—stomach cancer	0.00011	0.000405	CcSEcCtD
Temsirolimus—Thrombocytopenia—Methotrexate—stomach cancer	0.00011	0.000405	CcSEcCtD
Temsirolimus—Chest pain—Epirubicin—stomach cancer	0.00011	0.000404	CcSEcCtD
Temsirolimus—Myalgia—Epirubicin—stomach cancer	0.00011	0.000404	CcSEcCtD
Temsirolimus—Arthralgia—Epirubicin—stomach cancer	0.00011	0.000404	CcSEcCtD
Temsirolimus—Anxiety—Epirubicin—stomach cancer	0.000109	0.000402	CcSEcCtD
Temsirolimus—Skin disorder—Methotrexate—stomach cancer	0.000109	0.000401	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000109	0.000401	CcSEcCtD
Temsirolimus—Asthenia—Capecitabine—stomach cancer	0.000108	0.000398	CcSEcCtD
Temsirolimus—Anorexia—Methotrexate—stomach cancer	0.000107	0.000394	CcSEcCtD
Temsirolimus—Pruritus—Capecitabine—stomach cancer	0.000107	0.000393	CcSEcCtD
Temsirolimus—Leukopenia—Doxorubicin—stomach cancer	0.000107	0.000393	CcSEcCtD
Temsirolimus—Diarrhoea—Docetaxel—stomach cancer	0.000107	0.000392	CcSEcCtD
Temsirolimus—Oedema—Epirubicin—stomach cancer	0.000105	0.000387	CcSEcCtD
Temsirolimus—Anaphylactic shock—Epirubicin—stomach cancer	0.000105	0.000387	CcSEcCtD
Temsirolimus—Infection—Epirubicin—stomach cancer	0.000105	0.000384	CcSEcCtD
Temsirolimus—Cough—Doxorubicin—stomach cancer	0.000104	0.000383	CcSEcCtD
Temsirolimus—Convulsion—Doxorubicin—stomach cancer	0.000103	0.00038	CcSEcCtD
Temsirolimus—Diarrhoea—Capecitabine—stomach cancer	0.000103	0.00038	CcSEcCtD
Temsirolimus—Nervous system disorder—Epirubicin—stomach cancer	0.000103	0.000379	CcSEcCtD
Temsirolimus—Dizziness—Docetaxel—stomach cancer	0.000103	0.000379	CcSEcCtD
Temsirolimus—Thrombocytopenia—Epirubicin—stomach cancer	0.000103	0.000379	CcSEcCtD
Temsirolimus—Hypertension—Doxorubicin—stomach cancer	0.000103	0.000379	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000103	0.000377	CcSEcCtD
Temsirolimus—Skin disorder—Epirubicin—stomach cancer	0.000102	0.000376	CcSEcCtD
Temsirolimus—Insomnia—Methotrexate—stomach cancer	0.000102	0.000374	CcSEcCtD
Temsirolimus—Myalgia—Doxorubicin—stomach cancer	0.000102	0.000373	CcSEcCtD
Temsirolimus—Arthralgia—Doxorubicin—stomach cancer	0.000102	0.000373	CcSEcCtD
Temsirolimus—Chest pain—Doxorubicin—stomach cancer	0.000102	0.000373	CcSEcCtD
Temsirolimus—Anxiety—Doxorubicin—stomach cancer	0.000101	0.000372	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000101	0.000371	CcSEcCtD
Temsirolimus—Anorexia—Epirubicin—stomach cancer	0.0001	0.000369	CcSEcCtD
Temsirolimus—Dyspnoea—Methotrexate—stomach cancer	0.0001	0.000369	CcSEcCtD
Temsirolimus—Somnolence—Methotrexate—stomach cancer	0.0001	0.000367	CcSEcCtD
Temsirolimus—Dizziness—Capecitabine—stomach cancer	9.99e-05	0.000367	CcSEcCtD
Temsirolimus—Vomiting—Docetaxel—stomach cancer	9.92e-05	0.000365	CcSEcCtD
Temsirolimus—Rash—Docetaxel—stomach cancer	9.84e-05	0.000362	CcSEcCtD
Temsirolimus—Dermatitis—Docetaxel—stomach cancer	9.83e-05	0.000361	CcSEcCtD
Temsirolimus—Decreased appetite—Methotrexate—stomach cancer	9.78e-05	0.000359	CcSEcCtD
Temsirolimus—Headache—Docetaxel—stomach cancer	9.78e-05	0.000359	CcSEcCtD
Temsirolimus—Anaphylactic shock—Doxorubicin—stomach cancer	9.74e-05	0.000358	CcSEcCtD
Temsirolimus—Oedema—Doxorubicin—stomach cancer	9.74e-05	0.000358	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Methotrexate—stomach cancer	9.71e-05	0.000357	CcSEcCtD
Temsirolimus—Fatigue—Methotrexate—stomach cancer	9.7e-05	0.000356	CcSEcCtD
Temsirolimus—Infection—Doxorubicin—stomach cancer	9.68e-05	0.000356	CcSEcCtD
Temsirolimus—Pain—Methotrexate—stomach cancer	9.62e-05	0.000353	CcSEcCtD
Temsirolimus—Vomiting—Capecitabine—stomach cancer	9.61e-05	0.000353	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Epirubicin—stomach cancer	9.59e-05	0.000352	CcSEcCtD
Temsirolimus—Nervous system disorder—Doxorubicin—stomach cancer	9.55e-05	0.000351	CcSEcCtD
Temsirolimus—Thrombocytopenia—Doxorubicin—stomach cancer	9.54e-05	0.00035	CcSEcCtD
Temsirolimus—Rash—Capecitabine—stomach cancer	9.53e-05	0.00035	CcSEcCtD
Temsirolimus—Insomnia—Epirubicin—stomach cancer	9.52e-05	0.00035	CcSEcCtD
Temsirolimus—Dermatitis—Capecitabine—stomach cancer	9.52e-05	0.00035	CcSEcCtD
Temsirolimus—Headache—Capecitabine—stomach cancer	9.47e-05	0.000348	CcSEcCtD
Temsirolimus—Skin disorder—Doxorubicin—stomach cancer	9.46e-05	0.000348	CcSEcCtD
Temsirolimus—Dyspnoea—Epirubicin—stomach cancer	9.39e-05	0.000345	CcSEcCtD
Temsirolimus—Somnolence—Epirubicin—stomach cancer	9.36e-05	0.000344	CcSEcCtD
Temsirolimus—Anorexia—Doxorubicin—stomach cancer	9.29e-05	0.000341	CcSEcCtD
Temsirolimus—Nausea—Docetaxel—stomach cancer	9.27e-05	0.000341	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Methotrexate—stomach cancer	9.2e-05	0.000338	CcSEcCtD
Temsirolimus—Decreased appetite—Epirubicin—stomach cancer	9.15e-05	0.000336	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Epirubicin—stomach cancer	9.09e-05	0.000334	CcSEcCtD
Temsirolimus—Fatigue—Epirubicin—stomach cancer	9.08e-05	0.000334	CcSEcCtD
Temsirolimus—Pain—Epirubicin—stomach cancer	9e-05	0.000331	CcSEcCtD
Temsirolimus—Constipation—Epirubicin—stomach cancer	9e-05	0.000331	CcSEcCtD
Temsirolimus—Nausea—Capecitabine—stomach cancer	8.98e-05	0.00033	CcSEcCtD
Temsirolimus—Abdominal pain—Methotrexate—stomach cancer	8.89e-05	0.000327	CcSEcCtD
Temsirolimus—Body temperature increased—Methotrexate—stomach cancer	8.89e-05	0.000327	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Doxorubicin—stomach cancer	8.88e-05	0.000326	CcSEcCtD
Temsirolimus—Insomnia—Doxorubicin—stomach cancer	8.81e-05	0.000324	CcSEcCtD
Temsirolimus—Dyspnoea—Doxorubicin—stomach cancer	8.69e-05	0.000319	CcSEcCtD
Temsirolimus—Somnolence—Doxorubicin—stomach cancer	8.66e-05	0.000318	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Epirubicin—stomach cancer	8.61e-05	0.000316	CcSEcCtD
Temsirolimus—Decreased appetite—Doxorubicin—stomach cancer	8.47e-05	0.000311	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Doxorubicin—stomach cancer	8.41e-05	0.000309	CcSEcCtD
Temsirolimus—Fatigue—Doxorubicin—stomach cancer	8.4e-05	0.000309	CcSEcCtD
Temsirolimus—Pain—Doxorubicin—stomach cancer	8.33e-05	0.000306	CcSEcCtD
Temsirolimus—Constipation—Doxorubicin—stomach cancer	8.33e-05	0.000306	CcSEcCtD
Temsirolimus—Abdominal pain—Epirubicin—stomach cancer	8.32e-05	0.000306	CcSEcCtD
Temsirolimus—Body temperature increased—Epirubicin—stomach cancer	8.32e-05	0.000306	CcSEcCtD
Temsirolimus—Hypersensitivity—Methotrexate—stomach cancer	8.29e-05	0.000305	CcSEcCtD
Temsirolimus—Asthenia—Methotrexate—stomach cancer	8.07e-05	0.000297	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Doxorubicin—stomach cancer	7.97e-05	0.000293	CcSEcCtD
Temsirolimus—Pruritus—Methotrexate—stomach cancer	7.96e-05	0.000292	CcSEcCtD
Temsirolimus—Hypersensitivity—Epirubicin—stomach cancer	7.76e-05	0.000285	CcSEcCtD
Temsirolimus—Body temperature increased—Doxorubicin—stomach cancer	7.7e-05	0.000283	CcSEcCtD
Temsirolimus—Abdominal pain—Doxorubicin—stomach cancer	7.7e-05	0.000283	CcSEcCtD
Temsirolimus—Diarrhoea—Methotrexate—stomach cancer	7.7e-05	0.000283	CcSEcCtD
Temsirolimus—Asthenia—Epirubicin—stomach cancer	7.55e-05	0.000278	CcSEcCtD
Temsirolimus—Pruritus—Epirubicin—stomach cancer	7.45e-05	0.000274	CcSEcCtD
Temsirolimus—Dizziness—Methotrexate—stomach cancer	7.44e-05	0.000273	CcSEcCtD
Temsirolimus—Diarrhoea—Epirubicin—stomach cancer	7.2e-05	0.000265	CcSEcCtD
Temsirolimus—Hypersensitivity—Doxorubicin—stomach cancer	7.18e-05	0.000264	CcSEcCtD
Temsirolimus—Vomiting—Methotrexate—stomach cancer	7.15e-05	0.000263	CcSEcCtD
Temsirolimus—Rash—Methotrexate—stomach cancer	7.09e-05	0.000261	CcSEcCtD
Temsirolimus—Dermatitis—Methotrexate—stomach cancer	7.09e-05	0.00026	CcSEcCtD
Temsirolimus—Headache—Methotrexate—stomach cancer	7.05e-05	0.000259	CcSEcCtD
Temsirolimus—Asthenia—Doxorubicin—stomach cancer	6.99e-05	0.000257	CcSEcCtD
Temsirolimus—Dizziness—Epirubicin—stomach cancer	6.96e-05	0.000256	CcSEcCtD
Temsirolimus—Pruritus—Doxorubicin—stomach cancer	6.89e-05	0.000253	CcSEcCtD
Temsirolimus—Vomiting—Epirubicin—stomach cancer	6.69e-05	0.000246	CcSEcCtD
Temsirolimus—Nausea—Methotrexate—stomach cancer	6.68e-05	0.000246	CcSEcCtD
Temsirolimus—Diarrhoea—Doxorubicin—stomach cancer	6.67e-05	0.000245	CcSEcCtD
Temsirolimus—Rash—Epirubicin—stomach cancer	6.64e-05	0.000244	CcSEcCtD
Temsirolimus—Dermatitis—Epirubicin—stomach cancer	6.63e-05	0.000244	CcSEcCtD
Temsirolimus—Headache—Epirubicin—stomach cancer	6.6e-05	0.000242	CcSEcCtD
Temsirolimus—Dizziness—Doxorubicin—stomach cancer	6.44e-05	0.000237	CcSEcCtD
Temsirolimus—Nausea—Epirubicin—stomach cancer	6.25e-05	0.00023	CcSEcCtD
Temsirolimus—Vomiting—Doxorubicin—stomach cancer	6.19e-05	0.000228	CcSEcCtD
Temsirolimus—Rash—Doxorubicin—stomach cancer	6.14e-05	0.000226	CcSEcCtD
Temsirolimus—Dermatitis—Doxorubicin—stomach cancer	6.14e-05	0.000225	CcSEcCtD
Temsirolimus—Headache—Doxorubicin—stomach cancer	6.1e-05	0.000224	CcSEcCtD
Temsirolimus—Nausea—Doxorubicin—stomach cancer	5.79e-05	0.000213	CcSEcCtD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.78e-05	9.98e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—APOA1—stomach cancer	1.78e-05	9.96e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PDHA1—stomach cancer	1.77e-05	9.91e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ECHS1—stomach cancer	1.77e-05	9.91e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—TYMP—stomach cancer	1.76e-05	9.89e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—FADS1—stomach cancer	1.76e-05	9.89e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SERPINE1—stomach cancer	1.75e-05	9.85e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ADRB2—stomach cancer	1.73e-05	9.71e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.73e-05	9.7e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.71e-05	9.59e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—STAT3—stomach cancer	1.71e-05	9.58e-05	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—MAPK3—stomach cancer	1.71e-05	9.57e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PPP2R1A—stomach cancer	1.7e-05	9.52e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—RHOA—stomach cancer	1.69e-05	9.5e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.69e-05	9.49e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.69e-05	9.49e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6ST—stomach cancer	1.69e-05	9.47e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NOS3—stomach cancer	1.68e-05	9.4e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—TYMP—stomach cancer	1.66e-05	9.32e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—FADS1—stomach cancer	1.66e-05	9.32e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SREBF2—stomach cancer	1.65e-05	9.26e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTT1—stomach cancer	1.64e-05	9.19e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CASP8—stomach cancer	1.64e-05	9.17e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MAPK3—stomach cancer	1.63e-05	9.15e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—RORA—stomach cancer	1.63e-05	9.15e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6R—stomach cancer	1.63e-05	9.15e-05	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—MAPK1—stomach cancer	1.62e-05	9.1e-05	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—EGFR—stomach cancer	1.62e-05	9.1e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—APC—stomach cancer	1.62e-05	9.09e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYP2A6—stomach cancer	1.62e-05	9.08e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CDH1—stomach cancer	1.62e-05	9.07e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.61e-05	9.04e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PPP2R1A—stomach cancer	1.6e-05	8.98e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.6e-05	8.96e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MYC—stomach cancer	1.59e-05	8.9e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SMAD4—stomach cancer	1.57e-05	8.84e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—AKR1C3—stomach cancer	1.57e-05	8.83e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GSTP1—stomach cancer	1.57e-05	8.81e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ERBB2—stomach cancer	1.57e-05	8.79e-05	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—EGFR—stomach cancer	1.56e-05	8.74e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SREBF2—stomach cancer	1.55e-05	8.72e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MAPK1—stomach cancer	1.55e-05	8.7e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—EGFR—stomach cancer	1.55e-05	8.7e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—HMOX1—stomach cancer	1.55e-05	8.69e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—RORA—stomach cancer	1.54e-05	8.62e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ENO1—stomach cancer	1.53e-05	8.61e-05	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—KRAS—stomach cancer	1.53e-05	8.6e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALDOB—stomach cancer	1.53e-05	8.57e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—FBP1—stomach cancer	1.52e-05	8.55e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.52e-05	8.55e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CKB—stomach cancer	1.52e-05	8.55e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CA1—stomach cancer	1.52e-05	8.55e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6R—stomach cancer	1.51e-05	8.44e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FYN—stomach cancer	1.5e-05	8.39e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCL8—stomach cancer	1.49e-05	8.34e-05	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—KRAS—stomach cancer	1.47e-05	8.26e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.47e-05	8.24e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—KRAS—stomach cancer	1.47e-05	8.22e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—TYMS—stomach cancer	1.46e-05	8.19e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CDKN1B—stomach cancer	1.45e-05	8.14e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GSTM1—stomach cancer	1.44e-05	8.1e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALDOB—stomach cancer	1.44e-05	8.08e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PLIN2—stomach cancer	1.43e-05	8.04e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALOX5—stomach cancer	1.42e-05	7.97e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.42e-05	7.97e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SERPINE1—stomach cancer	1.41e-05	7.91e-05	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—PIK3CA—stomach cancer	1.41e-05	7.9e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FGFR2—stomach cancer	1.4e-05	7.87e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—DPYD—stomach cancer	1.4e-05	7.84e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CA2—stomach cancer	1.39e-05	7.82e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCND1—stomach cancer	1.38e-05	7.77e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—JUN—stomach cancer	1.38e-05	7.75e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	1.37e-05	7.67e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ERBB2—stomach cancer	1.36e-05	7.65e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CD44—stomach cancer	1.36e-05	7.64e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—RHOA—stomach cancer	1.36e-05	7.63e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NT5E—stomach cancer	1.36e-05	7.62e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PGAM1—stomach cancer	1.36e-05	7.62e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ERCC2—stomach cancer	1.36e-05	7.61e-05	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—PIK3CA—stomach cancer	1.35e-05	7.59e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PIK3CA—stomach cancer	1.35e-05	7.55e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NOS3—stomach cancer	1.35e-05	7.55e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MMP9—stomach cancer	1.34e-05	7.54e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CDKN1A—stomach cancer	1.34e-05	7.51e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALOX5—stomach cancer	1.34e-05	7.51e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—DPYD—stomach cancer	1.32e-05	7.39e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MAPK8—stomach cancer	1.31e-05	7.33e-05	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—HRAS—stomach cancer	1.3e-05	7.31e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.3e-05	7.27e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PLCE1—stomach cancer	1.3e-05	7.27e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IRS2—stomach cancer	1.29e-05	7.21e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—MTHFR—stomach cancer	1.28e-05	7.15e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CDKN1B—stomach cancer	1.26e-05	7.08e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—ERBB2—stomach cancer	1.26e-05	7.06e-05	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HRAS—stomach cancer	1.25e-05	7.02e-05	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IL6—stomach cancer	1.25e-05	7e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CAV1—stomach cancer	1.25e-05	6.99e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—HRAS—stomach cancer	1.25e-05	6.99e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APOA1—stomach cancer	1.24e-05	6.98e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—UMPS—stomach cancer	1.24e-05	6.97e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1B—stomach cancer	1.24e-05	6.96e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTT1—stomach cancer	1.24e-05	6.93e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTGS2—stomach cancer	1.23e-05	6.91e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP2A6—stomach cancer	1.22e-05	6.85e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—VEGFA—stomach cancer	1.21e-05	6.77e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—JUN—stomach cancer	1.2e-05	6.74e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—STAT3—stomach cancer	1.2e-05	6.71e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IL6—stomach cancer	1.19e-05	6.69e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—AKR1C3—stomach cancer	1.19e-05	6.67e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PRKCB—stomach cancer	1.19e-05	6.65e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6ST—stomach cancer	1.18e-05	6.63e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CAV1—stomach cancer	1.18e-05	6.6e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—APOA1—stomach cancer	1.17e-05	6.58e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CDKN1B—stomach cancer	1.17e-05	6.54e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CDKN1A—stomach cancer	1.17e-05	6.54e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTT1—stomach cancer	1.16e-05	6.53e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ENO1—stomach cancer	1.16e-05	6.5e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PPP2R1A—stomach cancer	1.16e-05	6.49e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PDHA1—stomach cancer	1.15e-05	6.48e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ECHS1—stomach cancer	1.15e-05	6.48e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP2A6—stomach cancer	1.15e-05	6.46e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MAPK3—stomach cancer	1.14e-05	6.41e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MAPK8—stomach cancer	1.14e-05	6.38e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APC—stomach cancer	1.14e-05	6.37e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTP1—stomach cancer	1.14e-05	6.37e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—AKR1C3—stomach cancer	1.12e-05	6.28e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—HMOX1—stomach cancer	1.12e-05	6.28e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MYC—stomach cancer	1.11e-05	6.23e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ENO1—stomach cancer	1.09e-05	6.12e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MAPK1—stomach cancer	1.09e-05	6.1e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EGFR—stomach cancer	1.09e-05	6.09e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—FADS1—stomach cancer	1.09e-05	6.09e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—TYMP—stomach cancer	1.09e-05	6.09e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	1.08e-05	6.08e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CDKN1A—stomach cancer	1.08e-05	6.04e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—TYMS—stomach cancer	1.06e-05	5.92e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6R—stomach cancer	1.05e-05	5.91e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTM1—stomach cancer	1.04e-05	5.85e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—STAT3—stomach cancer	1.04e-05	5.83e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PPARG—stomach cancer	1.03e-05	5.8e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CD44—stomach cancer	1.03e-05	5.76e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—KRAS—stomach cancer	1.03e-05	5.76e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SREBF2—stomach cancer	1.02e-05	5.7e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—RORA—stomach cancer	1e-05	5.64e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MAPK3—stomach cancer	9.93e-06	5.57e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SERPINE1—stomach cancer	9.87e-06	5.54e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ERCC2—stomach cancer	9.81e-06	5.5e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CD44—stomach cancer	9.68e-06	5.43e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—STAT3—stomach cancer	9.6e-06	5.39e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RHOA—stomach cancer	9.52e-06	5.34e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MAPK1—stomach cancer	9.45e-06	5.3e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—EGFR—stomach cancer	9.45e-06	5.3e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PIK3CA—stomach cancer	9.43e-06	5.29e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NOS3—stomach cancer	9.42e-06	5.29e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALDOB—stomach cancer	9.41e-06	5.28e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ALB—stomach cancer	9.3e-06	5.22e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—MTHFR—stomach cancer	9.22e-06	5.17e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MAPK3—stomach cancer	9.17e-06	5.15e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TP53—stomach cancer	9.12e-06	5.12e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—KRAS—stomach cancer	8.93e-06	5.01e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MYC—stomach cancer	8.92e-06	5e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—NOS3—stomach cancer	8.89e-06	4.99e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ERBB2—stomach cancer	8.81e-06	4.95e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALOX5—stomach cancer	8.75e-06	4.91e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PPP2R1A—stomach cancer	8.73e-06	4.9e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MAPK1—stomach cancer	8.73e-06	4.9e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—EGFR—stomach cancer	8.72e-06	4.89e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HRAS—stomach cancer	8.72e-06	4.89e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—DPYD—stomach cancer	8.61e-06	4.83e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTP1—stomach cancer	8.56e-06	4.81e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CAV1—stomach cancer	8.5e-06	4.77e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APOA1—stomach cancer	8.48e-06	4.76e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—HMOX1—stomach cancer	8.45e-06	4.74e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL8—stomach cancer	8.36e-06	4.69e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6—stomach cancer	8.35e-06	4.68e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—KRAS—stomach cancer	8.24e-06	4.62e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PPP2R1A—stomach cancer	8.23e-06	4.62e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PIK3CA—stomach cancer	8.2e-06	4.6e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CDKN1B—stomach cancer	8.16e-06	4.58e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTGS2—stomach cancer	8.13e-06	4.56e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTP1—stomach cancer	8.07e-06	4.53e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—TYMS—stomach cancer	7.96e-06	4.47e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—HMOX1—stomach cancer	7.96e-06	4.47e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTM1—stomach cancer	7.87e-06	4.42e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCND1—stomach cancer	7.79e-06	4.37e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—JUN—stomach cancer	7.77e-06	4.36e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTT1—stomach cancer	7.61e-06	4.27e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HRAS—stomach cancer	7.59e-06	4.26e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PIK3CA—stomach cancer	7.57e-06	4.25e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MMP9—stomach cancer	7.56e-06	4.24e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CDKN1A—stomach cancer	7.53e-06	4.23e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP2A6—stomach cancer	7.53e-06	4.22e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—TYMS—stomach cancer	7.5e-06	4.21e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PPARG—stomach cancer	7.47e-06	4.19e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTM1—stomach cancer	7.42e-06	4.16e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ERCC2—stomach cancer	7.4e-06	4.15e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MAPK8—stomach cancer	7.35e-06	4.13e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AKR1C3—stomach cancer	7.32e-06	4.11e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6—stomach cancer	7.26e-06	4.07e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ENO1—stomach cancer	7.13e-06	4e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HRAS—stomach cancer	7.01e-06	3.93e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ERCC2—stomach cancer	6.97e-06	3.91e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—MTHFR—stomach cancer	6.96e-06	3.9e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—VEGFA—stomach cancer	6.79e-06	3.81e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—STAT3—stomach cancer	6.72e-06	3.77e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ALB—stomach cancer	6.72e-06	3.77e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6—stomach cancer	6.7e-06	3.76e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—MTHFR—stomach cancer	6.55e-06	3.68e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—NOS3—stomach cancer	6.43e-06	3.61e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MAPK3—stomach cancer	6.42e-06	3.6e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CAV1—stomach cancer	6.42e-06	3.6e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOA1—stomach cancer	6.4e-06	3.59e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CD44—stomach cancer	6.33e-06	3.55e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MYC—stomach cancer	6.25e-06	3.5e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MAPK1—stomach cancer	6.11e-06	3.43e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EGFR—stomach cancer	6.11e-06	3.43e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CAV1—stomach cancer	6.05e-06	3.39e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOA1—stomach cancer	6.03e-06	3.38e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTGS2—stomach cancer	5.88e-06	3.3e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—KRAS—stomach cancer	5.77e-06	3.24e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PPARG—stomach cancer	5.64e-06	3.16e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPP2R1A—stomach cancer	5.38e-06	3.02e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PPARG—stomach cancer	5.32e-06	2.98e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PIK3CA—stomach cancer	5.3e-06	2.97e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTP1—stomach cancer	5.28e-06	2.96e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HMOX1—stomach cancer	5.2e-06	2.92e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TP53—stomach cancer	5.13e-06	2.88e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALB—stomach cancer	5.07e-06	2.85e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PIK3CA—stomach cancer	5e-06	2.81e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—TYMS—stomach cancer	4.91e-06	2.75e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HRAS—stomach cancer	4.91e-06	2.75e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—NOS3—stomach cancer	4.85e-06	2.72e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTM1—stomach cancer	4.85e-06	2.72e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALB—stomach cancer	4.78e-06	2.68e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6—stomach cancer	4.7e-06	2.63e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—NOS3—stomach cancer	4.57e-06	2.57e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ERCC2—stomach cancer	4.56e-06	2.56e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTGS2—stomach cancer	4.44e-06	2.49e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—MTHFR—stomach cancer	4.29e-06	2.4e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTGS2—stomach cancer	4.18e-06	2.35e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CAV1—stomach cancer	3.95e-06	2.22e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOA1—stomach cancer	3.94e-06	2.21e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PIK3CA—stomach cancer	3.62e-06	2.03e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPARG—stomach cancer	3.48e-06	1.95e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALB—stomach cancer	3.12e-06	1.75e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NOS3—stomach cancer	2.99e-06	1.68e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTGS2—stomach cancer	2.73e-06	1.53e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PIK3CA—stomach cancer	2.73e-06	1.53e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PIK3CA—stomach cancer	2.57e-06	1.44e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.68e-06	9.44e-06	CbGpPWpGaD
